- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/56 - IFN-alpha
Patent holdings for IPC class C07K 14/56
Total number of patents in this class: 577
10-year publication summary
|
28
|
36
|
29
|
34
|
48
|
34
|
28
|
37
|
36
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vib VZW | 882 |
35 |
| Universiteit Gent | 1338 |
33 |
| Orionis Biosciences BV | 83 |
30 |
| Orionis Biosciences Inc. | 95 |
24 |
| Modernatx, Inc. | 1262 |
22 |
| Centre National de La Recherche Scientifique | 10476 |
20 |
| Centre hospitalier Regional universitaire de Montpellier | 30 |
15 |
| CytomX Therapeutics, Inc. | 222 |
13 |
| Teva Pharmaceuticals Australia Pty Ltd | 30 |
13 |
| IBC Pharmaceuticals, Inc. | 93 |
12 |
| Universite de Montpellier | 991 |
11 |
| ILC Therapeutics Ltd | 27 |
10 |
| Glaxo Group Limited | 4053 |
9 |
| The Regents of the University of California | 20015 |
9 |
| Rutgers, The State University of New Jersey | 1894 |
9 |
| Ubiprotein, Corp. | 12 |
8 |
| President and Fellows of Harvard College | 5993 |
6 |
| Biosteed Gene Expression Tech. Co., Ltd. | 12 |
6 |
| ImmunGene Inc. | 12 |
6 |
| PharmaEssentia Corp. | 52 |
6 |
| Other owners | 280 |